Amarin (United States)

Amarin (United States)

Amarin Corporation is an Irish-American biopharmaceutical company founded in 1993 and headquartered in Dublin, Ireland and Bridgewater, New Jersey. The company develops and markets medicines for the treatment of cardiovascular disease. Derived from Wikipedia licensed CC-BY-SA.

Open Access statistics for Amarin (United States), United States, covering academic research published from 2005 to 2024. Read More.


Open Access Percentage

57%


Total
Publications

129


Total Open
Publications

73


Total
Citations

6.9K


Open Access
Percentage

57%


Total
Publications

129


Total Open
Publications

73


Total
Citations

6.9K

Wikipedia

Website

download

Breakdown

28% 25% 2% 45%

Publisher Open

28%

Both

25%

Other Platform Open

2%

Closed

45%

Percentage of Open Access over time

0%10%20%30%40%50%60%70%80%90%100%
20052006200720082009201020112012201320142015201620172018201920202021202220232024

Publisher Open

Both

Other Platform Open

Closed

Volume of Open Access over time

024681012141618202224Total Publications
20052006200720082009201020112012201320142015201620172018201920202021202220232024

Open

Closed

Publisher Open

39%OA Journal

OA Journal 39%

26

Hybrid 43%

29

No Guarantees 18%

12

Other Platform Open

Domain 92%

36

Institution 8%

3

Other Internet 8%

3

Preprint 3%

1

Public 0%

0

Other Platform Locations

Name

Platform Type

Publications

PubMed Central
Domain
36
Europe PMC
Domain
3
DOI
Other Internet
3
Research Square
Preprint
1
Le Centre pour la Communication Scientifique Directe - HAL - Diderot
Institution
1
Indiana University
Institution
1
Imperial College London
Institution
1
Harvard University
Institution
1
1 / 1

Data updated 18 August 2025

Share

Share

Share